Loading...

Sourcebio International Plc

SBI.LLSE
Healthcare
Medical - Diagnostics & Research
£115.00
£5.00(4.55%)

Sourcebio International Plc (SBI.L) Stock Competitors & Peer Comparison

See (SBI.L) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
SBI.L£115.00+4.55%0N/AN/AN/A
0QNO.L£573.20-0.66%39.1B14.50£39.52+0.69%
0KHE.L£87.79-5.44%10.7B14.68£6.16+0.31%
IDHC.L£0.36+0.85%206.4M8.88£0.04N/A
0G8X.L£0.46-1.24%186.1M-0.06-£7.81N/A
DXRX.L£133.50+0.00%112.8M-66.75-£0.02N/A
AGL.L£6.00+0.00%19.4M-1.20-£0.05N/A
YGEN.L£0.51-0.47%16.4M-0.51-£0.01N/A
ABDX.L£6.50+4.00%13.1M-6.75-£0.01N/A
PRM.L£3.04+0.00%9M-3.04-£0.01N/A
Showing 1 to 10 of 15 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

SBI.L vs 0QNO.L Comparison August 2025

SBI.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SBI.L stands at 0. In comparison, 0QNO.L has a market cap of 39.1B. Regarding current trading prices, SBI.L is priced at £115.00, while 0QNO.L trades at £573.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SBI.L currently has a P/E ratio of N/A, whereas 0QNO.L's P/E ratio is 14.50. In terms of profitability, SBI.L's ROE is +0.42%, compared to 0QNO.L's ROE of +0.07%. Regarding short-term risk, Volatility data is not available for a full comparison. SBI.L has daily volatility of N/A and 0QNO.L has daily volatility of 2.11.Check 0QNO.L's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;